Chlorogenic acid inhibits porcine deltacoronavirus release by targeting apoptosis

Int Immunopharmacol. 2024 Jan 25:127:111359. doi: 10.1016/j.intimp.2023.111359. Epub 2023 Dec 14.

Abstract

Porcine deltacoronavirus (PDCoV), belonging to family Coronaviridae, genus Deltacoronavirus, can cause acute diarrhea in piglets, and also possesses cross-species transmission potential, leading to severe economic losses and threatening public health. However, no approved drug against PDCoV infection is available. Here, we investigated the antiviral effect of chlorogenic acid (CGA), the main active component of Lonicerae Japonicae Flos, against PDCoV infection. The results showed that CGA inhibited the replication of PDCoV significantly both in LLC-PK1 and ST cells, with a selectivity index greater than 80. CGA decreased the synthesis of PDCoV viral RNA and protein, and viral titers in a dose-dependent manner. The results of the time-of-addition assay indicated that CGA mainly affected the early stage of virus replication and viral release. Moreover, CGA significantly reduced apoptosis caused by PDCoV infection, and the application of apoptosis agonist and inhibitor revealed that apoptosis could promote progeny virus release. Further study demonstrated that CGA can inhibit virus release by directly targeting apoptosis caused by PDCoV infection. In conclusion, CGA is an effective agent against PDCoV, which provides a foundation for drug development for the treatment of PDCoV and other coronavirus infections.

Keywords: Antiviral agent; Apoptosis; Chlorogenic acid; Coronavirus; Porcine deltacoronavirus; Viral release.

MeSH terms

  • Animals
  • Apoptosis
  • Chlorogenic Acid / pharmacology
  • Coronavirus Infections* / drug therapy
  • Coronavirus* / genetics
  • Coronavirus* / metabolism
  • Deltacoronavirus
  • Swine
  • Swine Diseases*

Substances

  • Chlorogenic Acid

Supplementary concepts

  • Porcine coronavirus HKU15